A Phase I, Open-Label Study to Assess the Absorption, Metabolism, Excretion, Safety and Tolerability of a Single Oral Dose of Radiolabeled [14C]-AZD0914 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Jun 2015
At a glance
- Drugs Zoliflodacin (Primary)
- Indications Gonorrhoea
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 11 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 14 Jan 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.